Literature DB >> 3196150

Comparative hepatotoxicity and metabolism of N-methylformamide in rats and mice.

K Tulip1, J A Timbrell.   

Abstract

N-methylformamide (NMF) produced dose-dependent zone 3 haemorrhagic necrosis in mice; the threshold dose was 100-200 mg/kg. In rats a dose of 1000 mg/kg caused hepatic damage in some animals and slight elevations of plasma transaminases. A species difference in susceptibility to NMF-induced hepatotoxicity is clearly indicated. NMF depleted liver non-protein sulphydryl (NPSH) in a dose-dependent manner in mice, but not in rats. Depletion of liver glutathione by buthionine sulphoximine or diethylmaleate potentiated the hepatotoxicity of NMF in mice. [14C]-methyl NMF was metabolised by mice and rats and a number of urinary metabolites including an N-acetylcysteine conjugate, methylamine and N-hydroxymethylformamide were detected. There were no qualitative differences in the metabolites between rats and mice but mice metabolised NMF much faster and more extensively than rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196150     DOI: 10.1007/bf00570135

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  26 in total

1.  Metabolism studies of N,N-dimethylformamide. I. Studies in rats and dogs.

Authors:  G Kimmerle; A Eben
Journal:  Int Arch Arbeitsmed       Date:  1975

2.  Retardation of growth of Ehrlich ascites tumor by formamides and related compounds.

Authors:  A FURST; W C CUTTING; H GROSS
Journal:  Cancer Res       Date:  1955-06       Impact factor: 12.701

3.  Effects of N-methylformamide and related compounds in mouse sarcoma 180.

Authors:  D A CLARKE; F S PHILIPS; S S STERNBERG; R K BARCLAY; C C STOCK
Journal:  Proc Soc Exp Biol Med       Date:  1953-10

4.  A proton magnetic resonance study of the metabolism of N-methylformamide in the rat.

Authors:  K Tulip; J A Timbrell; J K Nicholson; I Wilson; J Troke
Journal:  Drug Metab Dispos       Date:  1986 Nov-Dec       Impact factor: 3.922

5.  The metabolism of benzyl isothiocyanate and its cysteine conjugate.

Authors:  G Brüsewitz; B D Cameron; L F Chasseaud; K Görler; D R Hawkins; H Koch; W H Mennicke
Journal:  Biochem J       Date:  1977-01-15       Impact factor: 3.857

6.  The effects of diethyldithiocarbamate on the hepatotoxic action and antitumor activity of N-methylformamide in mice.

Authors:  Y Masuda; N Nakayama; M Yasoshima
Journal:  Jpn J Pharmacol       Date:  1986-04

7.  The fate of N-methylformamide in mice. Routes of elimination and characterization of metabolites.

Authors:  P Kestell; A Gescher; J A Slack
Journal:  Drug Metab Dispos       Date:  1985 Sep-Oct       Impact factor: 3.922

8.  Hepatotoxicity of N-methylformamide in mice--I. Relationship to glutathione status.

Authors:  P G Pearson; A Gescher; E S Harpur
Journal:  Biochem Pharmacol       Date:  1987-02-01       Impact factor: 5.858

9.  Phase I study of N-methylformamide in patients with advanced cancer.

Authors:  D S Ettinger; D W Orr; A P Rice; R C Donehower
Journal:  Cancer Treat Rep       Date:  1985-05

10.  N-methylformamide: antitumour activity and metabolism in mice.

Authors:  A Gescher; N W Gibson; J A Hickman; S P Langdon; D Ross; G Atassi
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

View more
  2 in total

1.  Hepatotoxicity and P-4502E1-dependent metabolic oxidation of N,N-dimethylformamide in rats and mice.

Authors:  E Chieli; M Saviozzi; S Menicagli; T Branca; P G Gervasi
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

2.  Biological monitoring of workers exposed to N,N-dimethylformamide by determination of the urinary metabolites, N-methylformamide and N-acetyl-S-(N-methylcarbamoyl) cysteine.

Authors:  T Sakai; H Kageyama; T Araki; T Yosida; T Kuribayashi; Y Masuyama
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.